fluocinolone acetonide has been researched along with Acute Generalised Exanthematous Pustulosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alniemi, DT; Bridges, AG; Camilleri, MJ; Davis, MD; El-Azhary, RA; McEvoy, MT; Wetter, DA | 1 |
1 other study(ies) available for fluocinolone acetonide and Acute Generalised Exanthematous Pustulosis
| Article | Year |
|---|---|
Acute generalized exanthematous pustulosis: clinical characteristics, etiologic associations, treatments, and outcomes in a series of 28 patients at Mayo Clinic, 1996-2013.
Topics: Acute Generalized Exanthematous Pustulosis; Administration, Cutaneous; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clindamycin; Dermatitis; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Fluocinonide; Humans; Hydrocortisone; Male; Middle Aged; Mucous Membrane; Prednisone; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Triamcinolone; Young Adult | 2017 |